Antimicrobial-induced neutropenia in patients receiving OPAT or COpAT: A large multisite retrospective cohort study
COIN can be effectively identified and managed by a multidisciplinary team reviewing routine laboratory monitoring, enabling most patients to safely complete antimicrobial treatment.
Authors
- Kelsey Jensen (ORCID: https://orcid.org/0000-0001-8372-3316)
- A. L. Abel (ORCID: https://orcid.org/0000-0002-1965-0674)
- Margaret Pertzborn (ORCID: https://orcid.org/0000-0002-9898-7266)
- Abinash Virk (ORCID: https://orcid.org/0000-0003-3437-7159)
- Christina G. Rivera (ORCID: https://orcid.org/0000-0002-8308-3264)
- Peter Martin (ORCID: https://orcid.org/0000-0001-7813-1551)
- Kristin Cole (ORCID: https://orcid.org/0000-0002-8783-0191)
- Douglas W. Challener (ORCID: https://orcid.org/0000-0002-6964-9639)
- M. C. Edwards (ORCID: https://orcid.org/0000-0002-1561-1942)
- Omar Abu Saleh (ORCID: https://orcid.org/0000-0003-4955-5544)
Institutions
- Mayo Clinic (US)
- Alliance for Clinical Trials in Oncology (US)
- Mayo Clinic Health System (US)
- Mayo Clinic in Arizona (US)
- Mayo Clinic in Florida (US)
Publication Details
- Journal
- American Journal of Health-System Pharmacy
- Published
- 2025-04-09
- DOI
- https://doi.org/10.1093/ajhp/zxaf086
- Primary Topic
- Blood disorders and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00